BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21476380)

  • 1. Patent foramen ovale: thromboembolic structure or incidental finding?
    Torbey E; Thompson PD
    Conn Med; 2011 Feb; 75(2):97-105. PubMed ID: 21476380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent foramen ovale--assessment and treatment.
    Irwin B; Ray S
    Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine and patent foramen ovale: state of the science.
    Fuller CJ; Jesurum JT
    Crit Care Nurs Clin North Am; 2009 Dec; 21(4):471-91. PubMed ID: 19951764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patent foramen ovale and migraine: a causal or casual relationship?].
    Balbi M; Canepa M; Cheli M; Brunelli C
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):88S-92S. PubMed ID: 21416834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of patent foramen ovale: a current review of associated conditions and treatment.
    Johansson MC; Eriksson P; Dellborg M
    Int J Cardiol; 2009 May; 134(1):17-24. PubMed ID: 19232760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine and patent foramen ovale: connecting flight or one-way ticket?
    Rigatelli G
    Expert Rev Neurother; 2008 Sep; 8(9):1331-7. PubMed ID: 18759545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptogenic stroke and patent foramen ovale.
    Thaler DE; Saver JL
    Curr Opin Cardiol; 2008 Nov; 23(6):537-44. PubMed ID: 18830067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI
    Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Migraine as predictive factor of the presence of atrial septum aneurysm in patients with stroke and patent foramen ovale].
    Martín Balbuena S; Fuentes B; Lara M; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E
    Neurologia; 2009 Apr; 24(3):160-4. PubMed ID: 19418291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    Mas JL; Derumeaux G; Guillon B; Massardier E; Hosseini H; Mechtouff L; Arquizan C; Béjot Y; Vuillier F; Detante O; Guidoux C; Canaple S; Vaduva C; Dequatre-Ponchelle N; Sibon I; Garnier P; Ferrier A; Timsit S; Robinet-Borgomano E; Sablot D; Lacour JC; Zuber M; Favrole P; Pinel JF; Apoil M; Reiner P; Lefebvre C; Guérin P; Piot C; Rossi R; Dubois-Randé JL; Eicher JC; Meneveau N; Lusson JR; Bertrand B; Schleich JM; Godart F; Thambo JB; Leborgne L; Michel P; Pierard L; Turc G; Barthelet M; Charles-Nelson A; Weimar C; Moulin T; Juliard JM; Chatellier G;
    N Engl J Med; 2017 Sep; 377(11):1011-1021. PubMed ID: 28902593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale and cerebrovascular diseases.
    Desai AJ; Fuller CJ; Jesurum JT; Reisman M
    Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):446-55. PubMed ID: 16874357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Migraine, stroke and patent foramen ovale--connected or not?].
    Vuković V; Aleksić-Shihabi A; Lovrencić-Huzjan A; Demarin V
    Acta Med Croatica; 2008 May; 62(2):197-203. PubMed ID: 18710084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Percutaneous closure of patent foramen ovale: a wise approach].
    Gaspardone A; Iani C; Papa M
    G Ital Cardiol (Rome); 2008 Sep; 9(9):593-602. PubMed ID: 18783080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale closure and migraine: science and sensibility.
    Gupta VK
    Expert Rev Neurother; 2010 Sep; 10(9):1409-22. PubMed ID: 20819012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine, stroke and patent foramen ovale: a dangerous trio?
    Butera G; Agostoni E; Biondi-Zoccai G; Bresolin N; Fumagalli L; Chessa M; Gallanti A; Scacciatela P; Carminati M
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):233-8. PubMed ID: 18301138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent Foramen Ovale and Stroke.
    Sun YP; Homma S
    Circ J; 2016 Jul; 80(8):1665-73. PubMed ID: 27334127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.